Skip to content

Clinical trials

Phase 1/2 Carcinoma, Renal Cell trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 1/2 Status: Unknown status Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20092
20111
20132
20141
20163
20171
20182
20201
20213
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affiliated Hospital to Academy of Military Medical Sciences1
Consorzio Oncotech1
Eutilex1
Fuzhou General Hospital1
Hadassah Medical Organization1
Institut Bergonié1
King Faisal Specialist Hospital & Research Center1
NGM Biopharmaceuticals, Inc1
Qingdao University1
Shenzhen BinDeBio Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell21
Carcinoma, Non-Small-Cell Lung5
Carcinoma, Hepatocellular4
Colorectal Neoplasms4
Stomach Neoplasms4
Melanoma3
Mesothelioma3
Breast Neoplasms2
Carcinoma, Transitional Cell2
Esophageal Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.